Loading asset research
20/20 Biolabs Inc. Common Stock
AIDXNasdaq · USD · StocksQuote as of · Exchange session not verified$0.47
-2.08%
Today
AIDX
Loading 1D prices…
Market cap
$6M
Volume
26.7K
52w high
$50.0052w low
$0.40Company profile
20/20 Biolabs Inc. Common Stock
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.
Sector
Other
Industry
Services-Testing Laboratories
Exchange
Nasdaq
Display currency
USD
Location
Gaithersburg, MD, United States
Employees
4
Fiscal year end
1231
CIK
1139685
Session & valuation
Open$0.46
Previous close$0.48
Day high$0.48
Day low$0.46
30-day avg. volume80.9K
Outstanding shares12.8M
Diluted EPS-$0.76
Latest annual period
P/E (trailing)-0.62
P/E (forward)—
Price / book3.57
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 8734
Exact regulatory industry matches, ranked by nearest market capitalization.